Cerecin 
Welcome,         Profile    Billing    Logout  
 1 Product   0 Diseases  1 Product   1 Trial   88 News 
6 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
tricaprilin (CER-0001) / Cerecin
NCT04187547: A Phase III Multi Regional Clinical Trial (MRCT) of Tricaprilin in Mild to Moderately Severe Probable Alzheimer's Disease With Optional Open Label Extension

Withdrawn
3
344
NA
Tricaprilin, AC-SD-03, Placebo, AC-SD-03P
Cerecin
Alzheimer's Disease
12/23
02/24
NCT05809908: Tricaprilin Phase 3 ALTER-AD (Alternative-Alzheimer Disease) Study

Not yet recruiting
3
535
NA
Tricaprilin, Placebo
Cerecin
Alzheimer Disease
08/28
08/28
NCT05028114: Tricaprilin Liquid Formulation PK Study

Terminated
1
71
RoW
AC-1202, AC-OLE-01, AC-OLE-02, AC-OLE-03, AC-OLE-04, AC-OLE-05, AC-OLE-06, AC-OLE-07, AC-OLE-08, AC-OLE-09, AC-OLE-010, AC-OLE-P
Cerecin
Alzheimer Disease
03/22
07/22
NCT05408780: A Phase 1, Two-part, Randomized Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a Liquid Formulation of Tricaprilin and Matching Placebo in Healthy Subjects

Completed
1
45
US
AC-OLE-01-VA
Cerecin
Alzheimer Disease
08/22
10/22
NCT05628636: AC-OLE-01-VA Tolerability Study in Healthy Participants Under Different Dosing Conditions

Completed
1
18
RoW
AC-OLE-01-VA
Cerecin
Alzheimer Disease
12/22
04/23
NCT04727970: Tricaprilin Infantile Spasms Pilot Study

Completed
1
8
RoW
Tricaprilin, AC-OL-01
Cerecin
Infantile Spasm
12/23
12/23

Download Options